Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Moodys
Cerilliant
Deloitte
Julphar
UBS
Federal Trade Commission
Merck
Cipla

Generated: February 25, 2018

DrugPatentWatch Database Preview

GANTRISIN Drug Profile

« Back to Dashboard

When do Gantrisin patents expire, and what generic alternatives are available?

Gantrisin is a drug marketed by Roche and is included in five NDAs.

The generic ingredient in GANTRISIN is sulfisoxazole. There are three drug master file entries for this compound. Additional details are available on the sulfisoxazole profile page.
Drug patent expirations by year for GANTRISIN
Medical Subject Heading (MeSH) Categories for GANTRISIN

US Patents and Regulatory Information for GANTRISIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche GANTRISIN sulfisoxazole diolamine INJECTABLE;INJECTION 006917-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche GANTRISIN sulfisoxazole acetyl SYRUP;ORAL 009182-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche GANTRISIN sulfisoxazole diolamine OINTMENT;OPHTHALMIC 008414-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche GANTRISIN sulfisoxazole diolamine SOLUTION/DROPS;OPHTHALMIC 007757-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche GANTRISIN PEDIATRIC sulfisoxazole acetyl SUSPENSION;ORAL 009182-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche GANTRISIN sulfisoxazole TABLET;ORAL 006525-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Colorcon
Julphar
Harvard Business School
QuintilesIMS
Johnson and Johnson
Chinese Patent Office
Mallinckrodt
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot